Scholarlink

<p>Glioma is a common malignant tumor of the central nervous system associated with poor prognosis, highlighting the urgent need for novel tumor suppressors. Here, we identify SERPINI1 (a serpini family member) as a tumor suppressor in glioma, with a focus on glioblastoma (GBM). Integrative analysis of TCGA, GEO, and CGGA datasets demonstrated downregulation of SERPINI1 in glioma versus normal brain tissues, with lower SERPINI1 expression associated with higher tumor grade and worse clinical outcomes. Functional assays showed that SERPINI1 suppresses glioma cell proliferation, migration, and invasion of GBM cells. Mechanistically, IP-mass spectrometry identified 167 SERPINI1-interacting proteins, including VRK1 and VRK3, which are involved in critical oncogenic pathways. Key interactions were validated by co-IP and Western blot, as well as by immunofluorescence co-localization assays. Furthermore, structural prediction demonstrated that SERPINI1 specifically targets the catalytic domain of VRK1/VRK3, potentially modulating their activity. Our findings establish SERPINI1 as a novel tumor suppressor in GBM and highlight its regulatory network as a potential therapeutic target.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

SERPINI1 functions as a tumor suppressor in glioma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月2日

查看全文
  • Shuang Luo,
  • Chenyan Du,
  • Zhongmin Huang,
  • Hui Wang,
  • Jialin Chen,
  • Chong Han,
  • Hua Feng,
  • Peng Wang,
  • Shengtao Yao

摘要

Glioma is a common malignant tumor of the central nervous system associated with poor prognosis, highlighting the urgent need for novel tumor suppressors. Here, we identify SERPINI1 (a serpini family member) as a tumor suppressor in glioma, with a focus on glioblastoma (GBM). Integrative analysis of TCGA, GEO, and CGGA datasets demonstrated downregulation of SERPINI1 in glioma versus normal brain tissues, with lower SERPINI1 expression associated with higher tumor grade and worse clinical outcomes. Functional assays showed that SERPINI1 suppresses glioma cell proliferation, migration, and invasion of GBM cells. Mechanistically, IP-mass spectrometry identified 167 SERPINI1-interacting proteins, including VRK1 and VRK3, which are involved in critical oncogenic pathways. Key interactions were validated by co-IP and Western blot, as well as by immunofluorescence co-localization assays. Furthermore, structural prediction demonstrated that SERPINI1 specifically targets the catalytic domain of VRK1/VRK3, potentially modulating their activity. Our findings establish SERPINI1 as a novel tumor suppressor in GBM and highlight its regulatory network as a potential therapeutic target.